Reyon Pharmaceutical Company is Drug Discovery in South Korea that focus on Pharmaceutical Co Ltd business. Founded in 1964. They cover business area such as Reyon Pharmaceutical Co Ltd, distribution, specialty medicine, raw material, generic drug, original drug, drug substance, eye drop, injection, antibiotic, skeletal muscle relaxant, coagulation drug, anti-inflammatory enzyme, blood vessel, dialectic drug.
1964
( 60 years old in 2024 )
Pharmaceutical Co Ltd
-
43, Seobinggo-ro 91na-gil
Yongsan-gu
Seoul, 04397
South Korea
Private
Reyon Pharmaceutical Co Ltddistributionspecialty medicineraw materialgeneric drugoriginal drugdrug substanceeye dropinjectionantibioticskeletal muscle relaxantcoagulation druganti-inflammatory enzymeblood vesseldialectic drug
* We use standard office opening hours in near Reyon Pharmaceutical Company's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Reyon Pharmaceutical Company is Drug Discovery business from South Korea that founded in 1964 (60 years old in 2024), Reyon Pharmaceutical Company business is focusing on Pharmaceutical Co Ltd.
Reyon Pharmaceutical Company headquarter office and corporate office address is located in 43, Seobinggo-ro 91na-gil Yongsan-gu Seoul, 04397 South Korea.
Reyon Pharmaceutical Company was founded in South Korea.
In 2024, Reyon Pharmaceutical Company is currently focus on Pharmaceutical Co Ltd sector.
Above is snippet of Google Trends for "Pharmaceutical Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Reyon Pharmaceutical Company, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.